US Patent Issued to N.V. Nutricia on Dec. 30 for "Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases" (Dutch, German Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,273, issued on Dec. 30, was assigned to N.V. Nutricia (Zoetermeer, Netherlands).

"Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases" was invented by Saskia Braber (Zeist, Netherlands), Belinda Potappel - van 't Land (Utrecht, Netherlands), Selma Paulien Wiertsema (Utrecht, Netherlands), Johan Garssen (Utrecht, Netherlands), Bernd Stahl (Utrecht, Netherlands) and Marko Mank (Allendorf, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the use of beta1,3'-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barri...